Support Center

Appendix B to Part 40 — DOT Drug-Testing Semi-Annual Laboratory Report to Employers

Cross Reference

Link to an amendment published at 88 FR 27651, May 2, 2023

The following items are required on each laboratory report:

• Reporting Period (inclusive dates)
• Laboratory Identification (name and address)
• Employer Identification (name; may include Billing Code or ID code)
• C/TPA Identification (where applicable; name and address)

1. Specimen Results Reported (Total Number)

By Test Reason:

• (a) Pre-employment (number)
• (b) Post-accident (number)
• (c) Random (number)
• (d) Reasonable suspicion/cause (number)
• (e) Return-to-duty (number)
• (f) Follow-up (number)
• (g) Type of test not noted on CCF (number)

2. Specimens Reported

• (a) Negative (number)
• (b) Negative and dilute (number)

3. Specimens Reported as Rejected for Testing (Total Number)

By Reason:

• (a) Fatal flaw (number)
• (b) Uncorrected flaw (number)

4. Specimens Reported as Positive (Total Number)

By Drug:

• (a) Marijuana metabolite (number)
• (b) Cocaine metabolite (number)
• (c) Opioids (number)
  • (1) Codeine (number)
  • (2) Morphine (number)
  • (3) 6-AM (number)
  • (4) Hydrocodone (number)
  • (5) Hydromorphone (number)
  • (6) Oxycodone (number)
  • (7) Oxymorphone (number)
• (d) Phencyclidine (number)
• (e) Amphetamines (number)
  • (1) Amphetamine (number)
  • (2) Methamphetamine (number)
  • (3) MDMA (number)
  • (4) MDA (number)

5. Adulterated

(number)

6. Substituted

(number)

7. Invalid Result

(number)

[82 FR 52247, Nov. 13, 2017]